1. Role of Immunomodulators in SARS-CoV-2 Treatment: An In-Silico Study Using Network Biology
2. COVID-19: Role of Polyphenols as Immunomodulators
3. Herbal Formulation and COVID-19
4. COVID-19 Pandemic: Role of Ayurveda for Prevention and Treatment
5. Developing Vaccines Against COVID-19 and Immune Response
6. Traditional System of Medicine and Lifestyle for the Management, Prevention, and Treatment of COVID-19
7. Role of Synthetic Medicines as Immunomodulators for Cure of COVID-19
8. Immunomodulators New Emerging Virus Infections (Zika Virus Infection, MERS, and COVID-19)
9. COVID-19 Infection and Recent Investigations and Future Prospects
10. Advances of Traditional System of Medicine for COVID-19
The unique volume, COVID-19 and Immunomodulation with Special Emphasis on Nutraceutical and Herbal Formulation, covers recent advances in the management, prevention, and application of nutraceuticals and herbs in preventing and treating COVID-19. It demonstrates the beneficial immunomodulatory properties of nutraceuticals, spices, polyphenols, customary (traditional) medications, natural products, ayurveda, antioxidants, trace elements, vitamins, vaccines, etc., for COVID-19.
• Evaluates the benefits of herbal immunomodulators for safety and having fewer (if any) side effects, as opposed to conventional/artificial drugs
• Considers the role of ayurvedic medicines in the control and prevention of COVID-19 viruses
• Summarizes the most current discoveries and key factors of SARS-CoV-2 genetics, pathophysiology, and the host immune response
• Looks at the efficacy of vaccines against COVID-19 infection and the vaccines currently available
• Explains the pharmacological results alongside precise immunomodulator agents, like immunostimulators and immunosuppressants
• Looks at the containment and prevention strategies for COVID-19 infection and offers strategies for the future
The information provided here details how the use of selected nutraceuticals and herbals can be helpful, similarly to pharmacological remedies, in stopping some COVID-19-associated complications in infected patients. It will be a valuable resource for researchers in pharmaceutical science, medicine, COVID and related diseases, and others.
• Rajesh K. Kesharwani, PhD, MTech, is working as Associate Professor, Department of Computer Application, Nehru Gram Bharati (Deemed to be University), Prayagraj, India. He has more than 11 years of research and nine years of teaching experience at various institutes of India, imparting bioinformatics and biotechnology education. He has received several awards, including the NASI-SwarnaJayanti Puruskar by The National Academy of Sciences of India. He has supervised one PhD and more than 20 undergraduate and graduate students for their research work. Dr. Kesharwani has authored over 49 peer-reviewed articles, 20 book chapters, and 14 edited books with international publishers. He has been a member of many scientific communities as well as a reviewer for many international journals. He has presented many papers at various national and international conferences. Dr. Kesharwani received his PhD from the Indian Institute of Information Technology, Allahabad, and worked at NIT Warangal for two semesters. He has been a recipient of a Ministry of Human Resource Development (India) Fellowship and a Senior Research Fellowship from the Indian Council of Medical Research, India. His research fields of interest are medical informatics, protein structure and function prediction, computer-aided drug designing, structural biology, drug delivery, cancer biology, nanobiotechnology, and biomedical sciences.
• Raj K. Keservani, MPharm, is a Faculty of B. Pharmacy, CSM Group of Institutions, Allahabad, India. He has more than 12 years of academic (teaching) experience from various institutes of India in pharmaceutical education. He has published 31 peer-reviewed papers in the field of pharmaceutical sciences in national and international journals, 43 book chapters, three co-authored books, and 18 edited books. He is also active as a reviewer for several international scientific journals. Mr. Keservani graduated with a pharmacy degree from the Department of Pharmacy, Kumaun University, Nainital (Uttarakhand), India. He received his Master of Pharmacy (MPharm) (specialization in pharmaceutics) from the School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, India. Mr. Keservani is a life member of Society of Pharmaceutical Education and Research (SPER). His research interests include nutraceutical and functional foods, novel drug delivery systems (NDDS), transdermal drug delivery/drug delivery, health science, cancer biology, and neurobiology.